Drugplain

doxorubicin hydrochloride, Liposomal 2 mg/mL

doxorubicin hydrochloride · INJECTION, SUSPENSION, LIPOSOMAL · Baxter Healthcare Corporation

No Recall History
Plain English

Doxorubicin Hydrochloride, Liposomal is a chemotherapy medication given by injection into a vein to treat certain types of cancer. The liposomal formulation helps deliver the drug to cancer cells while potentially reducing some side effects compared to conventional doxorubicin.

Key Facts

Brand Name
doxorubicin hydrochloride, Liposomal
Generic Name
doxorubicin hydrochloride
NDC Code (Product)
0338-9581
Manufacturer
Baxter Healthcare Corporation
Strength
2 mg/mL
Dosage Form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Marketing Status
Marketing Start
12/19/2023

Recall History

No Recall History

Frequently Asked Questions

What is doxorubicin hydrochloride, Liposomal used for?

Doxorubicin Hydrochloride, Liposomal is a chemotherapy medication given by injection into a vein to treat certain types of cancer. The liposomal formulation helps deliver the drug to cancer cells while potentially reducing some side effects compared to conventional doxorubicin.

Is doxorubicin hydrochloride, Liposomal a controlled substance?

doxorubicin hydrochloride, Liposomal is not classified as a controlled substance by the DEA.

What is the generic name for doxorubicin hydrochloride, Liposomal?

The generic name for doxorubicin hydrochloride, Liposomal is doxorubicin hydrochloride. There are 11 other brand versions of doxorubicin hydrochloride.

What is the NDC code for doxorubicin hydrochloride, Liposomal 2 mg/mL?

The NDC (National Drug Code) for doxorubicin hydrochloride, Liposomal 2 mg/mL is 0338-9581, listed by Baxter Healthcare Corporation.